Tibotec (part of Johnson & Johnson)
Tibotec website: www.tibotec.com
🔎 Run a search for “Tibotec (part of Johnson & Johnson)”
Get RSS feed of these resultsAll stories
Author: Médecins Sans Frontières
Selon un rapport publié aujourd'hui par Médecins Sans Frontières (MSF) lors de la Conférence de l'International AIDS Society à Rome, plusieurs compagnies pharmaceutiques ont interrompu les programmes de réduction du coût des médicaments antirétroviraux...
Johnson & Johnson takes heat from Doctors Without Borders for not sharing HIV drug patents [USA]
Author: Susan Todd, Star Ledger [USA]
Doctors without Borders criticized Johnson & Johnson today for refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries…"Johnson & Johnson…has chosen to turn its...
J&J Generics Deal May Speed AIDS Drug Access in Africa, India
Author: Alex Nussbaum, Bloomberg [USA]
...Tibotec Pharmaceuticals [part of Johnson & Johnson]...has agreed to let three generic drugmakers provide copies of [its experimental AIDS drug] in sub-Saharan Africa, India and parts of Asia if it’s approved by regulators...[T]hat could make...
- Related companies: Johnson & Johnson Tibotec (part of Johnson & Johnson)
Author: AFP
Une "communauté de brevets" pour la production de médicaments à moindres coûts contre le sida va commencer à opérer à la mi-2010, a annoncé lundi soir la Facilité internationale d'achats de médicaments (Unitaid)... Cette création est le fruit de...
Boehringer, Gilead Freeze Antiretroviral Prices for Some U.S. Agencies [USA]
Author: Kaiser Daily HIV/AIDS Report [USA]
Pharmaceutical companies Boehringer Ingelheim and Gilead Sciences are freezing the prices of their antiretroviral drugs for select agencies in the U.S..."We urge the other drug companies to follow [Boehringer's] and Gilead's lead and to freeze price...
Microbicide Developer Receives License for Novel HIV Microbicide Candidate from Merck & Co., Inc.
Author: International Partnerships for Microbicides
…Merck & Co., Inc., has agreed to provide a royalty-free license to the non-profit International Partnership for Microbicides (IPM) to develop a novel antiretroviral compound for use as a potential vaginal microbicide…“Merck deserves recognition...
- Related companies: Bristol-Myers Squibb Gilead Sciences Johnson & Johnson Merck Tibotec (part of Johnson & Johnson)
Aspen to market last-resort Aids drug across Africa
Author: Samantha Enslin, Business Report [So. Africa]
Aspen plans to market a salvage treatment, Prezista, for Aids patients in 20 sub-Saharan African countries through a deal with Ireland's Tibotec Pharmaceuticals [a division of Johnson & Johnson (J&J)]...The deal was structured so that Aspen...
- Related companies: Aspen Pharmacare Johnson & Johnson Tibotec (part of Johnson & Johnson)
Author: Les Entreprises du Médicament [France]
[annexe présente exemples d’actions & partenariats des Entreprises du Médicament: Novartis, sanofi-aventis, MSD (Merck Sharp & Dohme, partie de Merck), Laboratoires Pierre Fabre, Bayer, Novo Nordisk (partie de Novo Group), GlaxoSmithKline,...
- Related stories: Rapport de responsabilité sociale des Entreprises du Médicament - engagements dans l’accès aux soins & médicaments, l’impact environnement, dialogue avec les parties prenantes
- Related companies: Abbott Laboratories Bayer Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly GlaxoSmithKline Johnson & Johnson Merck Merck Sharp & Dohme (part of Merck) Novartis Novo Group Novo Nordisk (part of Novo Group) Pfizer Procter & Gamble Roche Sanofi Schering-Plough Tibotec (part of Johnson & Johnson) Wyeth (part of Pfizer)
Pharma Companies Need to Keep Improving AIDS Response, Says ICCR and Nigerian Doctor
Author: William Baue, SocialFunds
In August 2006, the Interfaith Center on Corporate Responsibility (ICCR) produced the most thorough study of pharmaceutical company action on HIV/AIDS, documenting how the industry falls significantly short of best practice...The Business and Human...